Keruly J - Search Results

1

Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.

Sterling TR, Chaisson RE, Keruly J, Moore RD. Sterling TR, et al. Among authors: keruly j. J Infect Dis. 2003 Dec 1;188(11):1659-65. doi: 10.1086/379741. Epub 2003 Nov 14. J Infect Dis. 2003. PMID: 14639536

2

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Gallant JE, et al. Among authors: keruly j. J Infect Dis. 1992 Dec;166(6):1223-7. doi: 10.1093/infdis/166.6.1223. J Infect Dis. 1992. PMID: 1358986

3

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Chaisson RE, et al. Among authors: keruly j. Am Rev Respir Dis. 1992 Aug;146(2):285-9. doi: 10.1164/ajrccm/146.2.285. Am Rev Respir Dis. 1992. PMID: 1362634

4

Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.

Chaisson RE, Keruly J, Richman DD, Moore RD. Chaisson RE, et al. Among authors: keruly j. Arch Intern Med. 1992 Oct;152(10):2009-13. Arch Intern Med. 1992. PMID: 1417373

5

Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.

Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE. Moore RD, et al. Among authors: keruly j. AIDS. 1992 Jul;6(7):671-7. AIDS. 1992. PMID: 1503686 Clinical Trial.

6

Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.

Moore RD, Creagh-Kirk T, Keruly J, Link G, Wang MC, Richman D, Chaisson RE. Moore RD, et al. Among authors: keruly j. Arch Intern Med. 1991 May;151(5):981-6. Arch Intern Med. 1991. PMID: 1673837 Clinical Trial.

7

Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.

Easterbrook PJ, Keruly JC, Creagh-Kirk T, Richman DD, Chaisson RE, Moore RD. Easterbrook PJ, et al. Among authors: keruly jc. JAMA. 1991 Nov 20;266(19):2713-8. JAMA. 1991. PMID: 1942423

8

Neutropenia and bacterial infection in acquired immunodeficiency syndrome.

Moore RD, Keruly JC, Chaisson RE. Moore RD, et al. Among authors: keruly jc. Arch Intern Med. 1995 Oct 9;155(18):1965-70. Arch Intern Med. 1995. PMID: 7575050

9

Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.

Gallant JE, Moore RD, Keruly J, Richman DD, Chaisson RE. Gallant JE, et al. Among authors: keruly j. J Infect Dis. 1995 Aug;172(2):346-52. doi: 10.1093/infdis/172.2.346. J Infect Dis. 1995. PMID: 7622876 Clinical Trial.

10

Race, sex, drug use, and progression of human immunodeficiency virus disease.

Chaisson RE, Keruly JC, Moore RD. Chaisson RE, et al. Among authors: keruly jc. N Engl J Med. 1995 Sep 21;333(12):751-6. doi: 10.1056/NEJM199509213331202. N Engl J Med. 1995. PMID: 7643881 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters